The average cost for a Big Pharma ... more intricate and complex research areas, macroeconomic factors, tech advancements and high attrition rates; the pharma cohort spent $7.7 billion on trials ...

Returns on pharma R&D investment are at a nine ... areas such as oncology and neurology were driving up costs and the length of development cycles. This was despite the efforts of regulators ...

With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that ... be analysed during drug discovery and research, and is accelerating the pace ...

Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

Biocon's Siddharth Mittal challenges the feasibility of relocating pharma manufacturing to the US from China and India.

Adeosun urged Tinubu to redouble efforts at tackling the rising cost of drugs ... engagement of exited pharmaceutical companies to bring back investment in Research and Development (R&D) to ...

Experts say any added costs would be passed onto the ... a major impact on consumers but could impact the research and development areas of pharmaceutical companies. He explained that ...